Melanin Synthesis Inhibitor [EPC]

1138 reported adverse events

Drugs of this class: HYDROQUINONE FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN HYDROQUINONE, OCTINOXATE, AND OXYBENZONE PODOPHYLLUM PELTATUM, ASCORBICUM ACIDUM, GALIUM APARINE, HYDRASTIS CANADENSIS, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SARCOLACTICUM ACIDUM, THIAMINUM HYDROCHLORICUM, ALPHA-LIPOICUM ACIDUM, COLCHICUM AUTUMNALE, CONIUM MACULATUM, NATRUM OXALACETICUM, SULPHUR, VACCINIUM MYRTILLUS, NOREPINEPHRINE, ACETYLSALICYLICUM ACIDUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ANTHRACHINONUM, HISTAMINUM HYDROCHLORICUM, MAGNESIUM GLUCONICUM DIHYDRICUM, NADIDUM, NAPHTHOCHINONUM, PANTOTHENIC ACID, UBIDECARENONUM,

These side effects are most commonly reported by patients taking drugs of the Melanin Synthesis Inhibitor [EPC] class:

# Side effect Count
0 ERYTHEMA 176
1 DRUG INEFFECTIVE 166
2 CONDITION AGGRAVATED 104
3 SKIN BURNING SENSATION 100
4 PRURITUS 87
5 SKIN EXFOLIATION 81
6 PRODUCT USE IN UNAPPROVED INDICATION 75
7 DRY SKIN 68
8 RASH 66
9 INTENTIONAL PRODUCT USE ISSUE 58
See all common reactions for Melanin Synthesis Inhibitor [EPC]

Drugs of the Melanin Synthesis Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OCHRONOSIS 16 0.2254
1 CHLOASMA 9 0.0194
2 POST INFLAMMATORY PIGMENTATION CHANGE 6 0.0132
3 CHEMICAL INJURY 8 0.0098
4 NEOPLASM SKIN 15 0.0097
5 SKIN HYPOPIGMENTATION 15 0.0085
6 SQUAMOUS CELL CARCINOMA OF SKIN 44 0.0073
7 SKIN HYPERPIGMENTATION 54 0.0063
8 SKIN ATROPHY 23 0.0040
9 INCORRECT PRODUCT STORAGE 43 0.0033
See all enriched reactions for Melanin Synthesis Inhibitor [EPC]